Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway
在单克隆抗体(mAbs)靶向降钙素基因相关肽(CGRP)通路的情况下,开始使用新型急性偏头痛特异性药物(nAMSMs)的患者的治疗模式
期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-023-01678-y
Zhou, Zifan; Urman, Robert; Gill, Karminder; Park, Andrew S; Vuvu, Fiston; Patel, Leah B; Lu, Jingsong; Wade, Rolin L; Frerichs, Lindsay; Bensink, Mark E
单克隆抗体
偏头痛
信号转导
神经科学
多发性硬化症
CGRP